Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
British Journal of Haematology|March 1, 1996
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID miceA Terenzi, A Bolognesi, L Pasqualucci, et al.Clinical and Experimental Immunology|January 24, 2004
Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studiesG L Palmisano, P L Tazzari, E Cozzi, et al.British Journal of Cancer|January 1, 1997
B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's diseaseW C Vooijs, H G Otten, M van Vliet, et al.European Journal of Clinical Investigation|March 12, 2002
Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturationP H Gosselaar, A J G van-Dijk, G C de-Gast, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 10, 2001
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection modelP L Tazzari, L Polito, A Bolognesi, et al.Planta|January 9, 1998
New ribosome-inactivating proteins with polynucleotide:adenosine glycosidase and antiviral activities from Basella rubra L. and bougainvillea spectabilis WilldA Bolognesi, L Polito, F Olivieri, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Italian Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group Trials. GROCTA TrialsF Boccardo, A Rubagotti, D Amoroso, et al.Pageof 9